Tri Pointe Homes Announces Grand Opening, Sales Underway at The Knolls at Mountain House
Top-rated schools, abundant parks, and urban accessibility are some of the features that residents at The Knolls at Mountain House will appreciate. 'One of the many coveted features of living here in Mountain House is its commutability and location convenience,' said Carrie Newbery, VP Community Experience at Tri Pointe Homes. 'Mountain House is centrally located near freeways and is within an hour's drive to San Francisco, Sacramento, and San Jose. Plus, commuters have the option of accessing the nearby Tracy and Livermore train stations, and the Pleasanton BART station.'
The Knolls at Mountain House offers four unique floorplans, with versatile layouts that comfortably accommodate today's modern lifestyles, range from approximately 2,400 to 3,003 square feet. Designs offer up to five bedrooms, three-and-a-half baths, and two-bay garages. Open-concept plans are made for entertaining, with features like great rooms, lofts, and optional outdoor living areas. The gourmet kitchens include spacious islands, granite countertops and lots of included features; the coveted stainless steel and gas appliances within the homes are sure to create kitchen envy! Private GenSmart suites provide opportunities for multi-generational living, while a main-level bedroom and bath––a hard-to-find amenity in many new homes––serves as a wing for a home office or guest quarters. Standout options include a Spa Shower, a luxurious upgrade that further enhances the beautifully appointed primary bath. Pricing begins in the $1 Millions.
At The Knolls, the home are built with Tri Pointe Homes' LivingSmart® program, which incorporates energy-efficient technology and sustainable design features to enhance comfort, health, and long-term savings. The program focuses on five key areas: HealthSmart®, EnergySmart®, EarthSmart®, WaterSmart®, and HomeSmart®, ensuring that each home offers a greener, more connected living experience.
Mountain House residents enjoy a long list of community activities and events for all ages, including Saturday Farmer's Markets, Music in the Park, the Kite Festival, and the Independence Day Parade. One of the area's biggest highlights is its parks. Every neighborhood within Mountain House touts a five-acre village park with picnic areas, open fields, and play structures. Many offer hiking trails, ball fields, bocce courts, tennis courts, splash pads, and more. At The Knolls at Mountain House, residents will enjoy a large, eight-acre park with paved trails, volleyball courts, barbecue areas, and playground equipment.
For families seeking quality schools, The Knolls at Mountain House is zoned for Lammersville Unified School District, the highest-achieving school district in the San Joaquin Valley. LUSD includes seven elementary schools serving grades TK through 8 and one comprehensive high school. Students at Mountain House High School can also participate in dual enrollment at Delta College, conveniently located right in Mountain House, resulting in an AA degree at their high school graduation.
'Living at The Knolls at Mountain House gives you that rare combination of small-town serenity and big-city bustle when you need it,' said Newbery. 'Imagine meeting neighbors and making friends in your beautiful neighborhood surrounded by lush parks and peaceful nature. This truly is a special place where you can own a brand-new home with plenty of space to grow, yet still feel connected to the pulse of the city, whether it's for work or play.'
For more information, please call 925.414.0639, or join the interest group at www.tripointehomes.com/the-knolls-at-mountain-house.
About Tri Pointe Homes®
One of the largest homebuilders in the U.S., Tri Pointe Homes, Inc. (NYSE: TPH) is a publicly traded company operating in 12 states and the District of Columbia, and is a recognized leader in customer experience, innovative design, and environmentally responsible business practices. The company builds premium homes and communities with deep ties to the communities it serves— some for as long as a century. Tri Pointe Homes combines the financial resources, technology platforms and proven leadership of a national organization with the regional insights, longstanding community connections and agility of empowered local teams. Tri Pointe has won multiple Builder of the Year awards, was named to the 2024 Fortune World's Most Admired Companies™ list, is one of the 2023 Fortune 100 Best Companies to Work For® and was designated as one of the 2023 PEOPLE Companies That Care®. The company was also named as a Great Place To Work-Certified™ company for four years in a row (2021 through 2024), and was named on several Great Place To Work® Best Workplaces lists in 2022 and 2023. Building upon the legacy that was established more than 50 years ago under the name Quadrant Homes®, Tri Pointe Homes is an award-winning leader in the Washington real estate sector. For more information, please visit TriPointeHomes.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
A Once-in-a-Lifetime Opportunity: This Blue Chip Healthcare Stock Down 50% Could Double Your Money
Key Points Novo Nordisk's recent financial results and clinical progress haven't impressed Wall Street. However, the company can right the ship through innovation in its core specialty and elsewhere. The stock looks attractively valued at current levels and could beat the market over the next six years. 10 stocks we like better than Novo Nordisk › Investors looking to strike while the iron is hot can buy beaten-down stocks that appear to have excellent chances of bouncing back. And that describes shares of Novo Nordisk (NYSE: NVO) very well. The pharmaceutical leader is down by 52% over the trailing-12-month period as of July 17, but initiating a position now could double investors' money in six years or so. Here's why this stock is a screaming buy at its current levels. Novo Nordisk's recent challenges Novo Nordisk focuses on developing diabetes treatments, an area where it has been a leader for many decades. As of February, it held a 33.3% market share for diabetes drugs. This sort of long-term dominance doesn't happen by accident. The company has consistently attracted top talent in the pharmaceutical industry, which, combined with its extensive experience in diabetes, has enabled it to break new ground repeatedly. Why, then, have the company's shares dropped by 52% over the past year? Because Novo Nordisk failed to impress the market with its financial results and clinical progress. The developments that led to the drugmaker's share plunge would have been excellent for almost any other pharmaceutical company, but investors held it to a higher standard given its rich valuation metrics. For instance, the company reported phase 3 results for CagriSema, an investigational weight management medicine, that proved it's more effective than its famous semaglutide (Wegovy), reducing patients' weight by an average of 22.7% in 68 weeks. However, management was looking for a 25% figure in the study. Very few anti-obesity therapies in development have achieved results comparable to CagriSema, but that was not enough to please investors. The good news: Novo Nordisk's pipeline in diabetes and the fast-growing area of weight management remains robust. The company has several promising candidates in development, including Amycretin, for which it recently initiated late-stage studies. And management has significantly expanded its pipeline through acquisitions. Even with mounting competition, the company should continue to be one of the leaders in its core areas of focus. It's been developing medicines in other fields as well, including various rare diseases (such as the blood disorders beta thalassemia and sickle cell disease), neurological disorders (including Alzheimer's and Parkinson's), and others. Making progress in diabetes and obesity while diversifying its lineup should work wonders for Novo Nordisk down the line. The price is right Net sales in the first quarter grew by 19% year over year to 78.1 billion Danish krone ($12.1 billion). The company's net profit was up 14% year over year to $4.5 billion. These would be excellent results for most similarly sized drugmakers, yet Wall Street remains unimpressed. In my view, that has created a wonderful opportunity to buy shares on the dip. The company's forward price-to-earnings ratio (P/E) has declined significantly over the past year and now stands at 16.9, barely above the healthcare industry's 16.2 and lower than the S&P 500's 22.3. But given Novo Nordisk's still excellent position in its core markets of diabetes and obesity treatments -- the latter of which should grow rapidly in the coming years -- and the company's better-than-average revenue and earnings growth, its stock is arguably worth a steeper premium. In fact, the forward P/E is about as low as it has been in over two years. At current levels, shares look like a steal. Here is how things could evolve for the company in the next six years. First, it could make significant clinical and regulatory progress and launch at least one -- if not several -- blockbuster weight loss or diabetes medications. Second, the company should continue recording strong results, with revenue and earnings moving in the right direction. Lastly, it looks likely to continue increasing its dividend, which it has done significantly over the past half-decade. The stock needs a compound annual growth rate of 12.2% to double in the next six years. Novo Nordisk can pull it off, especially for those who opt to reinvest the dividend. Should you buy stock in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $652,133!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,056,790!* Now, it's worth noting Stock Advisor's total average return is 1,048% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025 Prosper Junior Bakiny has positions in Novo Nordisk. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. A Once-in-a-Lifetime Opportunity: This Blue Chip Healthcare Stock Down 50% Could Double Your Money was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21 minutes ago
- Yahoo
Lucid Soars on Multimillion Uber Deal -- Can It Go Higher Still?
Key Points Lucid claims to have the world's most advanced electric vehicles. Uber will invest $300 million into Lucid. Lucid will use tech provided by Nuro to outfit its vehicles for driverless Uber operations. 10 stocks we like better than Lucid Group › Famous investor Benjamin Graham said: "In the short run, the market is a voting machine, but in the long run, it is a weighing machine." That quote sure holds true today, after Uber Technologies (NYSE: UBER) shook up the market with its announcement that it will deploy a fleet of robotaxis as demand for autonomous driving vehicles begins to fire on all cylinders. If the market is indeed a short-term voting machine, the market has cast its vote, and Lucid Motors (NASDAQ: LCID) looks like the real winner of this partnership. Lucid's stock popped well over 40% on the news, while Uber traded marginally higher. Let's dig into what this massive development means for the young electric vehicle (EV) maker. Best of the best? When it comes to selecting partners for such a massive deal, Uber could have done a lot worse than selecting the EV company that's brash enough to claim "maker of the world's most advanced electric vehicles." More specifically, on Thursday, Uber announced a partnership that would unleash more than 20,000 robotaxis over the next six years. As previously mentioned, part of the partnership includes Lucid, but another partner is also in the mix: Nuro, an autonomous vehicle start-up. It breaks down like this: Uber will invest $300 million in Lucid, while Nuro develops the self-driving technology that Lucid will deploy in its vehicles to supply Uber with robotaxis. "This investment from Uber further validates Lucid's fully redundant zonal architecture and highly capable platform as ideal for autonomous vehicles, and our industry-leading range and spacious well-appointed interiors, as ideal for ridesharing," said Marc Winterhoff, Interim CEO at Lucid, in a press release. "This is the start of our path to extend our innovation and technology leadership into this multi-trillion-dollar market." This development is a pretty big deal for Lucid. While manufacturing of the 20,000 vehicles in question will be spread over six years and unlikely to start until late next year, it still represents a strong order for the company that just set a quarterly record for deliveries at only 3,309 vehicles, during the second quarter. Moreover, consider that Lucid delivered only 6,418 vehicles during the first half of 2025, and you can understand that 20,000 vehicles for Uber is nothing to sneeze at. In fact, it's about as many vehicles as Lucid hopes to deliver for the full year. Strategic change This partnership marks a new era for Uber, which previously exited the robotaxi space in 2020, and signals that the company's strategy going forward will revolve around partnerships with multiple technology developers. It's also not the only deal Uber is working on. In April, the company announced that Volkswagen will supply its vans for commercial service in Los Angeles next year. While Uber is the driving force behind this multi-million-dollar partnership, it arguably has the roughest road ahead. Driverless vehicle technology has been more challenging and more costly than anticipated, and it's dealing with tight regulations and federal investigations. Those hurdles caused many start-ups to close their doors, including General Motors' Cruise and Ford Motor Company's Argo AI. Uber also has some catching up to do in terms of driverless capabilities. Despite years of delays and missed targets, Tesla did start a pilot program with about a dozen Model Y EVs in Austin, Texas, in June, with plans to expand the service to other U.S. cities later this year. Waymo has also been methodically and quietly growing its operations for years in several U.S. cities with a fleet of roughly 1,500 vehicles. It just crossed 100 million miles of autonomous driving in July. Ultimately, this opens the door to new opportunities for all three companies. But if the market is indeed a voting machine in the short term, there is reason for Lucid investors to be excited. This gets the company's product in front of new customers, in a new addressable market, with partnerships that were once untapped -- it's a big deal, even aside from the $300 million investment. Lucid has a lot of momentum behind it right now, and if the Gravity SUV continues to accelerate its production and deliveries flawlessly, the young EV maker should enter 2026 poised for a tremendous year. While Lucid is likely to give back some of Thursday's large gains, there's little stopping Lucid's stock from climbing higher as deliveries ramp for the Gravity -- especially if the automaker can curb costs and cash burn in the year ahead. Should you buy stock in Lucid Group right now? Before you buy stock in Lucid Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Lucid Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $652,133!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,056,790!* Now, it's worth noting Stock Advisor's total average return is 1,048% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025 Daniel Miller has positions in Ford Motor Company and General Motors. The Motley Fool has positions in and recommends Tesla and Uber Technologies. The Motley Fool recommends General Motors and Volkswagen Ag. The Motley Fool has a disclosure policy. Lucid Soars on Multimillion Uber Deal -- Can It Go Higher Still? was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Upturn
2 hours ago
- Business Upturn
LexisNexis launches Protégé, a personalised AI assistant with agentic capabilities, to help UK lawyers to complete legal tasks more easily and efficiently
By GlobeNewswire Published on July 21, 2025, 04:01 IST LONDON, July 20, 2025 (GLOBE NEWSWIRE) — LexisNexis® Legal & Professional, a leading global provider of AI-powered legal analytics and decision tools, today announces a range of enhancements to Lexis+ AI and the UK launch of LexisNexis Protégé™. This personalised AI assistant intelligently supports legal practitioners in drafting, researching and advising their clients faster and more accurately, helping them focus on higher-value work. Built with the highest levels of security, compliance and privacy, Protégé is available across a wide range of LexisNexis products, including the Lexis+ AI® legal workflow solution and in the Microsoft Word drafting solution, Lexis® Create+. Developed responsibly with human oversight, the agentic AI capabilities in Protégé allow it to complete multi-step tasks, review its own output and suggest improvements, leaving lawyers free to focus on strategic work. Leveraging proprietary agentic and generative AI technology from LexisNexis, Protégé can: Draft full, tailored transactional documents. It can check its own work before turning to human legal professionals for a final review. Documents can be further edited directly in Lexis+ AI or in Microsoft Word. It can check its own work before turning to human legal professionals for a final review. Documents can be further edited directly in Lexis+ AI or in Microsoft Word. Suggest legal workflow actions based on the type of documents uploaded (e.g. draft a research note, summarise) and dynamically generate follow-up prompts personalised to the lawyer's workflow. based on the type of documents uploaded (e.g. draft a research note, summarise) and dynamically generate follow-up prompts personalised to the lawyer's workflow. Provide prompt assistance, proactively suggesting refinements to queries to help the user accomplish their goals efficiently. proactively suggesting refinements to queries to help the user accomplish their goals efficiently. Securely store tens of thousands of legal documents to a Vault . On each Vault, users can perform numerous AI tasks to summarise, draft, research and more. . On each Vault, users can perform numerous AI tasks to summarise, draft, research and more. Generate a graphical timeline of events from uploaded documents. 'LexisNexis is focused on improving outcomes and unlocking new levels of efficiency and value in legal work to support our customers' success,' said Gerry Duffy, Managing Director of LexisNexis UK. 'Our vision is for every legal professional to have a personalised AI assistant that makes their life better, and we're delighted to deploy that to the UK through our world-class, fully integrated AI technology platform.' Protégé can be tailored to each user by integrating with Document Management Systems (DMS). This allows users to query, extract clauses and draft from their firm or organisation's knowledge base, making it easier to access and apply relevant precedents. Supported DMS integrations include iManage, SharePoint and others. Through a customer-driven innovation programme, LexisNexis have developed Protégé by working closely with a number of customers across the industry. These firms included Eversheds Sutherland International and Irwin Mitchell. Eleanor Windsor, Partner and Director of Knowledge at Irwin Mitchell commented: 'Working closely with LexisNexis during the development of Protégé has given us the opportunity to help shape a tool that genuinely addresses the practical demands of legal work. The technology will save our teams time and allow them to focus more on strategic client matters.' The LexisNexis global technology platform seamlessly integrates each wave of AI innovation, including extractive AI, which finds relevant results within data and provides deep insights; generative AI, which creates new content from data based on user-entered prompts or instruction; and now agentic AI, which can intelligently and independently perform tasks on a user's behalf. To learn more about LexisNexis Protégé capabilities, visit To learn more about Lexis+ AI, visit About LexisNexis Legal & Professional LexisNexis® Legal & Professional provides legal, regulatory, and business information and analytics that help customers increase their productivity, improve decision-making, achieve better outcomes, and advance the rule of law around the world. As a digital pioneer, the company was the first to bring legal and business information online with its Lexis® and Nexis® services. LexisNexis Legal & Professional, which serves customers in more than 150 countries with 11,800 employees worldwide, is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
